Previous 10 | Next 10 |
home / stock / trumf / trumf news
2023-05-16 15:32:10 ET Terumo Corporation (TRUMF) Q4 2023 Results Conference Call May 15, 2023 04:30 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Antoinette Gawin - President & Chief Executive Officer Presentation N...
2023-05-15 09:33:25 ET Terumo press release ( OTCPK:TRUMF ): 2H GAAP EPS of ¥118.95. Revenue of ¥820.21B (+16.6% Y/Y). For further details see: Terumo GAAP EPS of ¥118.95, revenue of ¥820.21B
Terumo Corporation (TRUMF) Q3 2023 Earnings Conference Call February 09, 2023, 03:00 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Conference Call Participants Presentation Naoki Muto Hello. I am the CAFO, Muto. I wi...
Terumo press release ( OTCPK:TRUMF ): Q3 GAAP EPS of ¥93.21. Revenue of ¥617.99B (+18.1% Y/Y). For further details see: Terumo GAAP EPS of ¥93.21, revenue of ¥617.99B
Summary DexCom is young, innovative, admired, and (consequently) highly valued. Embecta is old, lethargic, lacks coverage, and (consequently) lowly valued. Growth and value investors may find respective equities interesting. I use DXCM and EMBC as a lens to view developments in ...
Terumo Corporation A. (TRUMF) Q2 2022 Earnings Conference Call November 10, 2022 07:00 AM ET Company Participants Shinjiro Sato - President & Chief Executive Officer Naoki Muto - Chief Accounting & Financial Officer Conference Call Participants ...
The following slide deck was published by Terumo Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Terumo Corporation 2022 Q3 - Results - Earnings Call Presentation
Summary Both Terumo and Johnson & Johnson are diversified members of the healthcare industry but with two opposite outlooks. Johnson & Johnson’s Q3 earnings highlighted the damaging effects of a strong dollar, regardless of the rebound in healthcare spending after t...
The following slide deck was published by Terumo Corporation in conjunction with their 2022 Q1 earnings call. For further details see: Terumo Corporation 2022 Q1 - Results - Earnings Call Presentation
Terumo Corporation (TRUMF) Q1 202 Earnings Conference Call August 9, 2022 4:00 A.M. ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Conference Call Participants Presentation Naoki Muto I am the CAFO, Muto. I will no...
News, Short Squeeze, Breakout and More Instantly...
Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market fo...
MicroVention-Terumo Announces New Leadership The Company Appoints New President and CEO PR Newswire ALISO VIEJO, Calif., Sept. 22, 2020 ALISO VIEJO, Calif. , Sept. 22, 2020 /PRNewswire/ -- MicroVention, Inc., a U.S. based subsidiary of Terumo and leading ...
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field Canada NewsWire TOKYO and DEVENTER, Netherlands, July 15, 2020 TOKYO and DEVENTER, Netherlands , July 15, 2020 /CNW/ -- Terumo Corporation (TSE: 4543) today announced it has completed the acquis...